BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29624319)

  • 1. [Interplay between HIV-1 and APOBEC].
    Sato K; Koyanagi Y
    Seikagaku; 2016; 88(5):569-75. PubMed ID: 29624319
    [No Abstract]   [Full Text] [Related]  

  • 2. The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process.
    Koma T; Doi N; Takemoto M; Watanabe K; Yamamoto H; Nakashima S; Adachi A; Nomaguchi M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest.
    Marelli S; Williamson JC; Protasio AV; Naamati A; Greenwood EJ; Deane JE; Lehner PJ; Matheson NJ
    Elife; 2020 Apr; 9():. PubMed ID: 32292164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC Enzymes as Targets for Virus and Cancer Therapy.
    Olson ME; Harris RS; Harki DA
    Cell Chem Biol; 2018 Jan; 25(1):36-49. PubMed ID: 29153851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
    Fan B; Cen S; Jiang JD
    Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.
    Uriu K; Kosugi Y; Ito J; Sato K
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of heat-shock protein 70 by prostaglandin A₁ inhibits HIV-1 Vif-mediated degradation of APOBEC3G.
    Sugiyama R; Abe M; Nishitsuji H; Murakami Y; Takeuchi H; Takaku H
    Antiviral Res; 2013 Sep; 99(3):307-11. PubMed ID: 23831493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection.
    Thangavelu PU; Gupta V; Dixit NM
    Virology; 2014 Jan; 449():224-8. PubMed ID: 24418556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the study of HIV-1 Vif and related inhibitors].
    Li ZY; Zhan P; Liu XY
    Yao Xue Xue Bao; 2010 Jun; 45(6):684-93. PubMed ID: 20939174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
    Ai Y; Ma J
    Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.
    Letko M; Booiman T; Kootstra N; Simon V; Ooms M
    Cell Rep; 2015 Dec; 13(9):1789-99. PubMed ID: 26628364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
    Mehle A; Wilson H; Zhang C; Brazier AJ; McPike M; Pery E; Gabuzda D
    J Virol; 2007 Dec; 81(23):13235-41. PubMed ID: 17898068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural resistance to HIV infection: The Vif-APOBEC interaction.
    Malim MH
    C R Biol; 2006 Nov; 329(11):871-5. PubMed ID: 17067930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis B virus and APOBEC family].
    Muramatsu M; Kitamura K; Wakae K
    Seikagaku; 2016 Oct; 88(5):557-62. PubMed ID: 29624316
    [No Abstract]   [Full Text] [Related]  

  • 17. Pokeweed antiviral protein restores levels of cellular APOBEC3G during HIV-1 infection by depurinating Vif mRNA.
    Krivdova G; Hudak KA
    Antiviral Res; 2015 Oct; 122():51-4. PubMed ID: 26275799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.
    Guerrero S; Libre C; Batisse J; Mercenne G; Richer D; Laumond G; Decoville T; Moog C; Marquet R; Paillart JC
    Sci Rep; 2016 Dec; 6():39507. PubMed ID: 27996044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.
    Rhee SY; Sankaran K; Varghese V; Winters MA; Hurt CB; Eron JJ; Parkin N; Holmes SP; Holodniy M; Shafer RW
    J Virol; 2016 Jul; 90(13):6058-6070. PubMed ID: 27099321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vif and Apobec3G in the innate immune response to HIV: a tale of two proteins.
    Farrow MA; Sheehy AM
    Future Microbiol; 2008 Apr; 3(2):145-54. PubMed ID: 18366335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.